INCY has clear efficacy so that should help ease any concerns about a new class of drug getting on the market. ARIA has efficacy and a bit of a rough safety profile, but that is a class effect that the FDA should be aware of.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.